Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2131-2140 of 2266 for

Edit search filters
  1. DNA and RNA Testing in Patients With Hereditary Cancer Syndromes

    Rochester, MN

  2. Tumor Infiltrating Lymphocytes Biobank

    Rochester, MN

  3. A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

    Scottsdale/Phoenix, AZ

  4. Intervention for Children Undergoing Proton Radiation for Brain Cancer

    Rochester, MN

  5. Grief Among Older Adult Family Caregivers

    Jacksonville, FL

  6. Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects

    Rochester, MN

  7. A Study to Assess Metabolic Changes in the Blood with Standard Treatment in Patients with Gliomas

    Rochester, MN

  8. Recruitment/Treatment of Minority Patients on Cancer Trials at Mayo Clinic

    Rochester, MN

  9. Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment

    Scottsdale/Phoenix, AZ

  10. A Study to Compare Subcutaneous Daratumumab with Intravenous Daratumumab

    Rochester, MN

.

Mayo Clinic Footer